Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Peng

Showing results (691-700 of 766) with videos related to

Pageof 77
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Hereditary stomatocytosis with PIEZO1 gene mutations: report of five cases and literature review]Y Li, X Zhao, J P Li, et al.
Current Molecular Medicine|June 10, 2016
LASS5 Interacts with SDHB and Synergistically Represses p53 and p21 ActivityZ Jiang, F Li, Y Wan, et al.
Journal of Medicinal Chemistry|April 12, 2001
Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycinesM G Natchus, R G Bookland, M J Laufersweiler, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 19, 2018
[Low-dose rituximab in IgA-mediated autoimmune hemolytic anemia: a case report and literatures review]Y Li, J P Li, Y Li, et al.
International Journal of Oral and Maxillofacial Surgery|July 30, 2019
Chinese expert group consensus on diagnosis and clinical management of osteoradionecrosis of the mandibleY He, C Ma, J Hou, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 24, 2021
[A descriptive analysis on body mass index distribution in adult twin pairs in China]H X Peng, W J Gao, J Lyu, et al.
Zhonghua Yi Xue Za Zhi|June 7, 2026
[Efficacy and safety of combining olorigliflozin with metformin in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy]Y F He, Z F Cheng, F Bian, et al.
Journal of Medicinal Chemistry|January 11, 2001
Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolinesM G Natchus, R G Bookland, B De, et al.
Molecular Cancer Therapeutics|April 10, 2015
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo CharacterizationDeborah S Mortensen, Kimberly E Fultz, Shuichan Xu, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
High throughput solid phase parallel synthesis of macrocyclic peptidomimeticsE Marsault, H R Hoveyda, M L Peterson, et al.
Pageof 77

Showing results (691-700 of 766) with videos related to

Sort By:
Pageof 77
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Hereditary stomatocytosis with PIEZO1 gene mutations: report of five cases and literature review]Y Li, X Zhao, J P Li, et al.
Current Molecular Medicine|June 10, 2016
LASS5 Interacts with SDHB and Synergistically Represses p53 and p21 ActivityZ Jiang, F Li, Y Wan, et al.
Journal of Medicinal Chemistry|April 12, 2001
Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycinesM G Natchus, R G Bookland, M J Laufersweiler, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 19, 2018
[Low-dose rituximab in IgA-mediated autoimmune hemolytic anemia: a case report and literatures review]Y Li, J P Li, Y Li, et al.
International Journal of Oral and Maxillofacial Surgery|July 30, 2019
Chinese expert group consensus on diagnosis and clinical management of osteoradionecrosis of the mandibleY He, C Ma, J Hou, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 24, 2021
[A descriptive analysis on body mass index distribution in adult twin pairs in China]H X Peng, W J Gao, J Lyu, et al.
Zhonghua Yi Xue Za Zhi|June 7, 2026
[Efficacy and safety of combining olorigliflozin with metformin in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy]Y F He, Z F Cheng, F Bian, et al.
Journal of Medicinal Chemistry|January 11, 2001
Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolinesM G Natchus, R G Bookland, B De, et al.
Molecular Cancer Therapeutics|April 10, 2015
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo CharacterizationDeborah S Mortensen, Kimberly E Fultz, Shuichan Xu, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
High throughput solid phase parallel synthesis of macrocyclic peptidomimeticsE Marsault, H R Hoveyda, M L Peterson, et al.
Pageof 77